* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.
A balanced portfolio built on the cornerstones of diversification and selectivity
Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.
Portfolio holdings
Top ten positions
Represents the top ten positions in NCDL based on Fair Value as of March 31, 2026
| Company | Fair value ($ in thousands) | Industry | Asset Types | Pricing1 |
|---|---|---|---|---|
| Solve Industrial Motion Group LLC | 905,827 | High Tech Industries | Subordinated Debt | 14.50% (PIK) |
| Venture Buyer, LLC (Velosio) | 222,487 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 5.25% |
| Exterro, Inc. | 9,310,548 | High Tech Industries | First Lien Debt | S + 5.25% |
| Solve Industrial Motion Group LLC | 2,408,702 | High Tech Industries | Subordinated Debt (Delayed Draw) | 14.50% (PIK) |
| Solve Industrial Motion Group LLC | 2,102,954 | High Tech Industries | Subordinated Debt | 14.50% (PIK) |
| Alta Buyer, LLC | -21,299 | High Tech Industries | Revolving Loan | S + 4.50% |
| Alta Buyer, LLC | 17,330,831 | High Tech Industries | First Lien Debt | S + 4.50% |
| Revalize Inc. (f/k/a AQ Holdco Inc.) | 3,805,100 | High Tech Industries | First Lien Debt (Delayed Draw) | 8.60% (Cash) 1.75% (PIK) |
| Revalize Inc. (f/k/a AQ Holdco Inc.) | 977,247 | High Tech Industries | First Lien Debt (Delayed Draw) | 8.60% (Cash) 1.75% (PIK) |
| Emburse, Inc. | 49 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 4.25% |
| Emburse, Inc. | 53 | High Tech Industries | Revolving Loan | S + 4.25% |
| Revalize Inc. (f/k/a AQ Holdco Inc.) | 216,692 | High Tech Industries | First Lien Debt (Delayed Draw) | 8.60% (Cash) 1.75% (PIK) |
| Eliassen Group, LLC | 831,178 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 5.75% |
| Eliassen Group, LLC | 11,547,428 | High Tech Industries | First Lien Debt | S + 5.75% |
| Prosci, Inc. | 4,713,927 | High Tech Industries | First Lien Debt | S + 4.50% |
| Ridge Trail US Bidco, Inc. (Options IT) | 3,567 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 4.50% |
| GNX HBS Holdings, LLC | 57,571 | High Tech Industries | Class A Units | |
| GNX HBS PARENT, LLC | -22,519 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 4.75% |
| YI, LLC (Young Innovations) | 15,883,229 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.75% |
| ARC Health OPCO, LLC | -34,230 | Healthcare & Pharmaceuticals | Subordinated Debt (Delayed Draw) | 8.00% (Cash) 5.00% (PIK) |
| Dermatology Intermediate Holdings III, Inc. (Forefront Dermatology) | 3,066,824 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.25% |
| JKC Buyer, Inc. (J. Knipper and Company Inc) | 2,052,143 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.50% |
| REP HS Holdings, LLC (HemaSource) | 802,607 | Healthcare & Pharmaceuticals | LP Interests | |
| ARC Health OPCO, LLC | 2,433,082 | Healthcare & Pharmaceuticals | Subordinated Debt | 8.00% (Cash) 5.00% (PIK) |
| JKC Buyer, Inc. (J. Knipper and Company Inc) | 5,928,413 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.50% |
| Heartland Veterinary Partners LLC | 10,812,638 | Healthcare & Pharmaceuticals | Subordinated Debt (Delayed Draw) | 7.50% (Cash) 7.00% (PIK) |
| GHR Healthcare, LLC | 1,834,353 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| GHR Healthcare, LLC | 5,864,129 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| GHR Healthcare, LLC | 4,565,614 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| GHR Healthcare, LLC | 7,450,934 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at March 31, 2026. As of March 31, 2026, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 3.66%, 3.68%, 3.70%, and 3.73% respectively. Certain investments are subject to a SOFR floor or may utilize an alternative reference rate such as U.S. Prime Rate (“P”). For fixed rate loans, a spread above a reference rate is not applicable.